<DOC>
	<DOCNO>NCT00438789</DOCNO>
	<brief_summary>The primary objective provide access eculizumab PNH patient pending commercial availability .</brief_summary>
	<brief_title>The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol</brief_title>
	<detailed_description />
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Hemoglobinuria</mesh_term>
	<criteria>PNH ; At least 18 year old Avoid conception ; Willing able give write informed consent Active bacterial infection Participation drug trial Pregnant breast feeding , intend conceive Not vaccinate N meningitidis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>